In vitro susceptibility of chloramphenicol against methicillin-resistant Staphylococcus aureus.

Abstract

Chloramphenicol has shown good in vitro activity against MRSA and is likely to have a key role in the treatment of MRSA infections providing us a good alternative to newer expensive antimicrobials in resource limited countries.